| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
β-blockade in sepsis: regulation of persisting sepsis-related tachycardia
|
Morelli, Andrea
|
|
|
8 |
9 |
p. 833-834
|
artikel
|
| 2 |
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
|
Karagiannidis, Christian
|
|
|
8 |
9 |
p. 853-862
|
artikel
|
| 3 |
Correction to Lancet Respir Med 2020; published online July 24. https://doi.org/10.1016/S2213-2600(20)30315-5
|
|
|
|
8 |
9 |
p. e71
|
artikel
|
| 4 |
COVID-19, asthma, and return to school
|
Abrams, Elissa M
|
|
|
8 |
9 |
p. 847-849
|
artikel
|
| 5 |
COVID-19 interstitial pneumonia: monitoring the clinical course in survivors
|
Raghu, Ganesh
|
|
|
8 |
9 |
p. 839-842
|
artikel
|
| 6 |
Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial
|
Kakihana, Yasuyuki
|
|
|
8 |
9 |
p. 863-872
|
artikel
|
| 7 |
Gender equity in interstitial lung disease
|
Kawano-Dourado, Leticia
|
|
|
8 |
9 |
p. 842-843
|
artikel
|
| 8 |
How COVID-19 could benefit tuberculosis and HIV services in South Africa
|
Keene, Claire
|
|
|
8 |
9 |
p. 844-846
|
artikel
|
| 9 |
Immunotherapy in lung cancer: effective for patients with poor performance status?
|
Alessi, Joao V
|
|
|
8 |
9 |
p. 838-839
|
artikel
|
| 10 |
Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
|
Nicolau, Dan V
|
|
|
8 |
9 |
p. 846-847
|
artikel
|
| 11 |
Integrated sports and respiratory medicine in the aftermath of COVID-19
|
Faghy, Mark A
|
|
|
8 |
9 |
p. 852
|
artikel
|
| 12 |
Living pig bioreactors can repair damaged donor lungs
|
Furlow, Bryant
|
|
|
8 |
9 |
p. e72
|
artikel
|
| 13 |
Lung cancer diagnosis can affect the whole family
|
Kirby, Tony
|
|
|
8 |
9 |
p. 850-851
|
artikel
|
| 14 |
Mortality in COVID-19 is not merely a question of resource availability
|
Becher, Tobias
|
|
|
8 |
9 |
p. 832-833
|
artikel
|
| 15 |
Particle sizes of infectious aerosols: implications for infection control
|
Fennelly, Kevin P
|
|
|
8 |
9 |
p. 914-924
|
artikel
|
| 16 |
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trial
|
Middleton, Gary
|
|
|
8 |
9 |
p. 895-904
|
artikel
|
| 17 |
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study
|
Pallett, Scott J C
|
|
|
8 |
9 |
p. 885-894
|
artikel
|
| 18 |
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
|
George, Peter M
|
|
|
8 |
9 |
p. 925-934
|
artikel
|
| 19 |
Pulmonary hypertension thresholds: time to lower further?
|
Provencher, Steeve
|
|
|
8 |
9 |
p. 834-836
|
artikel
|
| 20 |
Pulmonary vascular resistance and clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study
|
Maron, Bradley A
|
|
|
8 |
9 |
p. 873-884
|
artikel
|
| 21 |
SARS-CoV-2 viral load predicts COVID-19 mortality
|
Pujadas, Elisabet
|
|
|
8 |
9 |
p. e70
|
artikel
|
| 22 |
The EVALI outbreak and vaping in the COVID-19 era
|
The Lancet Respiratory Medicine,
|
|
|
8 |
9 |
p. 831
|
artikel
|
| 23 |
The time to do serosurveys for COVID-19 is now
|
Peeling, Rosanna W
|
|
|
8 |
9 |
p. 836-838
|
artikel
|
| 24 |
Time-varying intensity of mechanical ventilation and mortality in patients with acute respiratory failure: a registry-based, prospective cohort study
|
Urner, Martin
|
|
|
8 |
9 |
p. 905-913
|
artikel
|
Tijdschrift beschrijving